1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
3.8. Products in Pipeline
4. TECHNOLOGICAL OUTLOOK
5. RNA ANALYSIS MARKET BY TYPE
5.1. Introduction
5.2. Messenger RNA (mRNA)
5.3. Transfer RNA (tRNA)
5.4. Others
6. RNA ANALYSIS MARKET BY APPLICATION
6.1. Introduction
6.2. Reagnet
6.3. Kits
6.4. Enzymes
6.5. Others
7. RNA ANALYSIS MARKET BY END-USER
7.1. Introduction
7.2. Pharmaceutical & Biotech Companies
7.3. Academic & Research Institutes
7.4. Others
8. RNA ANALYSIS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Promega Corporation
10.2. Lexogen
10.3. Zymo Research
10.4. Azenta US, Inc
10.5. Shimadzu
10.6. Cofactor Genomics
10.7. Parse Biosciences
10.8. CD Genomics
10.9. Thermo Fisher Scientific Inc.
10.10. Illumina, Inc.
10.11. F. Hoffmann-La Roche Ltd
10.12. QIAGEN
10.13. Bio-Rad Laboratories, Inc.
10.14. Danaher Corporation
10.15. Agilent Technologies, Inc
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES